Compare Becton Dickinson and Co (BDX) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Peloton Interactive Inc — how do they compare? Becton Dickinson and Co trades at $156.1 (market cap $41.51B), while Peloton Interactive Inc trades at $6.37 (market cap $2.67B). The key difference: Becton Dickinson and Co is far larger — about 15.5× Peloton Interactive Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| BDX | PTON | |
|---|---|---|
Market Cap | $41.51B | $2.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $185.39 | $9.00 |
52-Week Low | $135.49 | $3.71 |
Enterprise Value | $57.97B | $3.27B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Peloton (PTON) trades at $6.08, up 3.75% on the day, as technical indicators show a bullish trend with neutral oscillators. The company has achieved a significant turnaround in cash flow, with operating cash flow positive at $333 million in 2025, and is projected to return to net profitability in 2026. However, revenue continues to decline, and the stock carries a high P/E ratio of 101.25, reflecting investor optimism about future earnings despite current challenges. Recent news highlights inclusion in the S&P SmallCap 600 index and leadership changes.
The outlook for PTON hinges on sustaining profitability and reversing revenue declines. Opportunities include strong free cash flow generation and cost-cutting success, but risks involve persistent revenue shrinkage, high debt levels, and intense competition. Analyst consensus is cautiously optimistic with a $7.50 price target, suggesting potential upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
